Mutations in Erlin1 and Erlin2 are linked to the development of hereditary spastic paraplegias SPG18 and SPG62 and amyotrophic lateral sclerosis (ALS)19–27. Here, ERLIN1 is linked to hereditary spastic paraplegia.